(1)
Autologous Bone Marrow-Derived Mesenchymal Stem Cells and Endothelial Progenitor Cells Transplantation Showed Potential Benefits for Type 2 Diabetes Mellitus Filipino Patients: A Case Series. Biomed. Res. Ther. 2024, 11 (4), 6326-6332. https://doi.org/10.15419/bmrat.v11i4.878.